Business news – Page 6
-
Business
Tornado at Pfizer plant accentuates US drug shortage issues
Perennial problem will not be addressed without major reforms to drug market
-
Business
Lapsed US chemical security programme leaves facilities vulnerable
Chemical Facility Anti-Terrorism Standards’ expiry means rules will not be enforced, and companies cannot vet new staff
-
News
European intellectual property system ready for gene-edited crops
Updates to New Genomic Technology regulations irrelevant to IP say experts
-
Feature
The drug developers fighting the antibiotic resistance problem
Andy Extance talks to the researchers innovating across different drug classes in the hunt to develop new treatments
-
Opinion
Resistant to change
Curbing industrial practices that drive antimicrobial resistance needs tighter regulation and enforcement
-
Business
How can we maintain the effectiveness of existing antimicrobials?
Reducing environmental pollution and tackling quality issues to stave off resistance
-
Feature
Who will pay for new antibiotics?
Governments around the world are starting to consider alternative funding models and incentives for antibiotics. Katrina Megget asks if it is enough
-
Opinion
Surviving in the war of all against all
Cancers and bacteria develop resistance to drugs in remarkably similar ways
-
Feature
Charting the rise in antimicrobial resistance
We look at the data behind antibiotic drug discovery and development, bacterial resistance and the financial problems with the current business model
-
Article
CPHI Barcelona 2023: forging collaborations for a promising future in the pharmaceutical sector
CPHI creates connections and inspires partnerships across the global pharma community
-
Opinion
Could cheap CRO rates threaten to destabilise biotech?
Pharmaceutical pipelines are heavily dependent on contract research organisations; we can’t afford for them to fail
-
Business
Fines upheld for Advanz Pharma over thyroid drug price increases
UK competition tribunal rules liothyronine pricing ’excessive’ and ‘deliberate’
-
Opinion
Navigating the literature torrent
It’s humanly impossible to filter and read everything worthwhile – let’s embrace assistance
-
Business
Antibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
-
Business
Biogen to cut 1000 more jobs by 2025
Biotech giant has also agreed to buy Reata Pharmaceuticals for $7.3 billion
-
Business
Illumina’s Grail quest results in epic fine
EU and US competition authorities object to firms completing merger without approval
-
Article
Mimicking our eyes’ sun protection
Sóliome is developing sunscreens based on natural UV-filtering peptides
-
Opinion
Who knew what? And when?
Finding the line between commercially sensitive information and public and environmental protection
-
Business
J&J subsidiary sues more talc researchers
Lawsuit claims another study linking talc use to cancer is fraudulent
-
Business
Revolutionising RSV prevention
New vaccines and a long-acting antibody aim to protect older adults and babies from respiratory syncytial virus